Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections

Uh Jin Kim1, Hee Kyung Kim1, Joon Hwan An1

  • 1Department of Infectious Diseases, Chonnam National University Medical School, Gwangju, Korea.

Chonnam Medical Journal
|September 18, 2014
PubMed

Insights

Carbapenem-resistant Acinetobacter infections are a growing threat in hospitals, particularly for critically ill patients. This review details their spread, resistance, and treatment challenges.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Critical Care Medicine

Background:

  • Carbapenem-resistant Acinetobacter species are significant nosocomial pathogens.
  • These infections are prevalent in intensive care units and critically ill patients.
  • Acquired resistance mechanisms complicate treatment and increase mortality.

Purpose of the Study:

  • To provide an updated review on carbapenem-resistant Acinetobacter infections.
  • To cover epidemiology, resistance mechanisms, and infection control.
  • To discuss treatment strategies and patient outcomes.

Main Methods:

  • Literature review of recent studies on carbapenem-resistant Acinetobacter.
  • Synthesis of data on epidemiology and resistance patterns.
  • Analysis of current treatment guidelines and outcomes.

Main Results:

  • Increasing prevalence of carbapenem-resistant Acinetobacter globally.
  • Diverse and complex resistance mechanisms identified.
  • Limited effective therapeutic options and high mortality rates.

Conclusions:

  • Carbapenem-resistant Acinetobacter poses a major challenge in healthcare settings.
  • Effective infection control and novel treatment strategies are crucial.
  • Further research is needed to combat these resistant pathogens.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
817
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
198
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
80
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
730
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.7K